Treatment Expectancies and Psilocybin vs Escitalopram for Depression

This secondary analysis of a randomized clinical trial examines the association between treatment expectancies and the relative efficacy of psilocybin compared with escitalopram for major depressive disorder.

Authors

Institutions

Publication Details

Journal
JAMA Psychiatry
Published
2024-12-10
DOI
https://doi.org/10.1001/jamapsychiatry.2024.4387
Citations
4
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
2.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment Expectancies and Psilocybin vs Escitalopram for Depression

Andrew D. Krystal, Ethan G. Dutcher
4 citations
JAMA Psychiatry
Psychedelics and Drug Studies
2.56
article

Treatment Expectancies and Psilocybin vs Escitalopram for Depression

Andrew D. Krystal, Ethan G. Dutcher
article en
4 citations

Abstract

This secondary analysis of a randomized clinical trial examines the association between treatment expectancies and the relative efficacy of psilocybin compared with escitalopram for major depressive disorder.

JAMA PsychiatryVol. 82(3)
University of California, San Francisco (US)
Good health and well-being
Openalex Percentile: Top 10%
Psychedelics and Drug Studies
2.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.